In today’s clinical research laboratories, available tissue samples are both smaller in size and more in demand for a variety of assays to help researchers make informed decisions and spatial discoveries.
The very cornerstone of tissue histopathology – the H&E stain – is the first crucial step to help map out the morphological landscape. Here, Akoya Biosciences describes a technique in which a tissue sample is stained with a modified H&E stain prior to the application of an Opal™ Multiplex assay on the same slide, as a screening tool and efficient and effective way to maximize your precious samples.
You will learn:
- Not all H&E is created equal. See how simulated H&E allows for superior morphological context
- The benefits of viewing H&E and multiplex stains on the same tissue.
- How to make the most out of your valuable tissue sections—conduct mIF and H&E on the same slide without using serial sections or tissue alignment software
- How Opal staining complements standard H&E analysis with a more quantitative and precise methodology.
Related Posts
Accelerate Building Custom Spatial Proteomic Panels for New Biological Insights
Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…